In this CME-certified interactive presentation, Kathleen Mullane, DO, PharmD, provides expert perspectives on optimal strategies for preventing and managing CMV infection in patients undergoing bone marrow transplantation.
In this downloadable slideset, Kathleen Mullane, DO, PharmD, provides expert perspectives on current and emerging strategies for preventing and managing CMV infection in patients undergoing bone marrow transplantation.
How might emerging investigational agents change the management of CMV infection in the post–hematopoietic cell transplantation setting? Here’s my take.
How has the approval of letermovir prophylaxis altered post-HCT CMV management? Here’s my take.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.